Evidence map›Paper›PMID 40004138›Full record

ArticleInternational journal of molecular sciences2025

Motor and Non-Motor Effects of Acute MPTP in Adult Zebrafish: Insights into Parkinson's Disease.

Niki Tagkalidou, Marija Stevanović, Irene Romero-Alfano, Gustavo Axel Elizalde-Velázquez, Selene Elizabeth Herrera-Vázquez, Eva Prats, Cristian Gómez-Canela, Leobardo Manuel Gómez-Oliván, Demetrio Raldúa

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Niki TagkalidouInstitute for Environmental Assessment and Water Research (IDAEA-CSIC), Jordi Girona, 18, 08034 Barcelona, Spain.
Marija StevanovićInstitute of Pesticides and Environmental Protection, Banatska 31b, 11080 Belgrade, Serbia.ORCID 0000-0003-3089-8192
Irene Romero-AlfanoDepartment of Analytical and Applied Chemistry, School of Engineering, Institut Químic de Sarrià-Universitat Ramon Llull, Via Augusta 390, 08017 Barcelona, Spain.
Gustavo Axel Elizalde-VelázquezLaboratorio de Toxicología Ambiental, Facultad de Química, Universidad Autónoma Del Estado de México, Paseo Colón Intersección Paseo Tollocan, Colonia Residencial Colón, Toluca CP 50120, Estado de México, Mexico.
Selene Elizabeth Herrera-VázquezLaboratorio de Toxicología Ambiental, Facultad de Química, Universidad Autónoma Del Estado de México, Paseo Colón Intersección Paseo Tollocan, Colonia Residencial Colón, Toluca CP 50120, Estado de México, Mexico.
Eva PratsResearch and Development Center (CID-CSIC), Jordi Girona, 18, 08034 Barcelona, Spain.ORCID 0000-0001-7838-2027
Cristian Gómez-CanelaDepartment of Analytical and Applied Chemistry, School of Engineering, Institut Químic de Sarrià-Universitat Ramon Llull, Via Augusta 390, 08017 Barcelona, Spain.ORCID 0000-0002-9073-6307
Leobardo Manuel Gómez-OlivánLaboratorio de Toxicología Ambiental, Facultad de Química, Universidad Autónoma Del Estado de México, Paseo Colón Intersección Paseo Tollocan, Colonia Residencial Colón, Toluca CP 50120, Estado de México, Mexico.ORCID 0000-0002-7248-3449
Demetrio RaldúaInstitute for Environmental Assessment and Water Research (IDAEA-CSIC), Jordi Girona, 18, 08034 Barcelona, Spain.ORCID 0000-0001-5256-1641

Funding

"Agencia Estatal de Investigación", from the Ministry of Science, Innovation and Universities PID2023-148502OB-C21 and C22European Union's Horizon Europe Research and Innovation Programme 101057014IDAEA-CSIC, Severo Ochoa Centre of Excellence CEX2018-000794-SMinistry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-66/2024-03/200214
6 · The paper itself

Abstract

Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to motor and non-motor symptoms. The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has been extensively used in different animal species to develop chemical models of PD. This study aimed to evaluate the effects of acute exposure to MPTP (3 × 150 mg/kg, intraperitoneally) on adult zebrafish by assessing the neurochemical, transcriptional, and motor changes associated with PD pathogenesis. MPTP treatment resulted in a significant decrease in brain catecholamines, including dopamine, norepinephrine, and normetanephrine. Additionally, a trend towards decreased levels of dopamine precursors (tyrosine and L-DOPA) and degradation products (3-MT and DOPAC) was also observed, although these changes were not statistically significant. Gene expression analysis showed the downregulation of

Indexed as

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineMotor ActivityMPTP PoisoningParkinson DiseaseAnimalsBehavior, AnimalBrainCatecholaminesDisease Models, AnimalDopamineDopaminergic NeuronsZebrafish1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineCatecholaminesDopamine1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineadult zebrafishhypokinesiaMPTPParkinson’s diseaseprepulse inhibitionpsychosisturning difficulties

Identifiers

PMID40004138
PMCPMC11855887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.